Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,437 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,010
Ph III recruiting: 99
Growth YoY: −1.7%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,348)

clinicaltrialsPublishedShowing 251–256 of 256 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06098313	HCT With PTCy in Higher-risk MDS	active not recruiting	Phase 2	113	Asan Medical CenterOTHER	1	Oct 24, 2023	clinicaltrials
NCT03825796	CPX-351 Plus Enasidenib for Relapsed AML	active not recruiting	Phase 2	2	Jonsson Comprehensive Cancer CenterOTHER	1	Sep 28, 2023	clinicaltrials
NCT04499573